Showing 2 results for Opportunities
December 14, 2018, 10:00 AM ET,
Executive Conference Center
The Biological Technologies Office is holding a Proposers Day to provide information on the structure and objectives of the Panacea program. Panacea aims to integrate systems pharmacology and advanced medicinal chemistry approaches to expand the human drug target space for therapeutic interventions in the areas of acute management of pain and inflammation and the improvement of physiological endurance under oxygen-limited conditions or environments. Panacea will support the development and proof-of-concept demonstration of a new integrated platform for the rapid prediction, synthesis, and validation of pharmacological interventions.
Military service members and veterans face serious occupational trauma; one
element in particular relates to the significantly increased risk of acute
and chronic neuropsychiatric conditions. Neuropsychiatric conditions in the
military are particularly impactful because options for treating them are
limited. No therapy currently exists that can deliver rapid relief of
neuropsychiatric symptoms and is reasonable for use in a broad spectrum of
conditions. Neuropsychiatric conditions are complex, and presentation is
highly subject to significant inter-individual variability. Focused Pharma
aims to develop new drugs that target specific neurotransmitter receptor
signaling modes to deliver near immediate relief that is generalizable
across indications and individuals.